Rafarma Pharmaceuticals Stock Price History

RAFA Stock  USD 0.09  0.03  47.54%   
If you're considering investing in Rafarma Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Rafarma Pharmaceuticals stands at 0.09, as last reported on the 16th of December 2024, with the highest price reaching 0.09 and the lowest price hitting 0.08 during the day. Rafarma Pharmaceuticals is out of control given 3 months investment horizon. Rafarma Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of 0.16, which implies the firm had a 0.16% return per unit of risk over the last 3 months. We were able to analyze and collect data for twenty-eight different technical indicators, which can help you to evaluate if expected returns of 2.34% are justified by taking the suggested risk. Use Rafarma Pharmaceuticals Semi Deviation of 9.7, risk adjusted performance of 0.0948, and Coefficient Of Variation of 850.13 to evaluate company specific risk that cannot be diversified away.
  
Rafarma Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.1561

Best PortfolioBest Equity
Good Returns
Average ReturnsRAFA
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 15.02
  actual daily
96
96% of assets are less volatile

Expected Return

 2.34
  actual daily
46
54% of assets have higher returns

Risk-Adjusted Return

 0.16
  actual daily
12
88% of assets perform better
Based on monthly moving average Rafarma Pharmaceuticals is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Rafarma Pharmaceuticals by adding it to a well-diversified portfolio.

Rafarma Pharmaceuticals Pink Sheet Price History Chart

There are several ways to analyze Rafarma Stock price data. The simplest method is using a basic Rafarma candlestick price chart, which shows Rafarma Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceOctober 30, 20240.12
Lowest PriceOctober 7, 20240.033

Rafarma Pharmaceuticals December 16, 2024 Pink Sheet Price Synopsis

Various analyses of Rafarma Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Rafarma Pink Sheet. It can be used to describe the percentage change in the price of Rafarma Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Rafarma Pink Sheet.
Rafarma Pharmaceuticals Price Rate Of Daily Change 1.48 
Rafarma Pharmaceuticals Price Daily Balance Of Power 2.90 
Rafarma Pharmaceuticals Accumulation Distribution 3,306 
Rafarma Pharmaceuticals Price Action Indicator 0.02 

Rafarma Pharmaceuticals December 16, 2024 Pink Sheet Price Analysis

When benchmark price declines in a down market, there may be an uptick in Rafarma Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Rafarma Pharmaceuticals intraday prices and daily technical indicators to check the level of noise trading in Rafarma Stock and then apply it to test your longer-term investment strategies against Rafarma.

Rafarma Pink Sheet Price History Data

The price series of Rafarma Pharmaceuticals for the period between Tue, Sep 17, 2024 and Mon, Dec 16, 2024 has a statistical range of 0.09 with a coefficient of variation of 40.25. The price distribution for the period has arithmetic mean of 0.07. The median price for the last 90 days is 0.07. The company completed stock split (1:10) on 20th of November 2012.
OpenHighLowCloseVolume
12/16/2024 0.08  0.09  0.08  0.09  29,755 
12/13/2024 0.06  0.08  0.06  0.06  11,925 
12/12/2024 0.07  0.07  0.07  0.07  1.00 
12/11/2024 0.06  0.07  0.06  0.07  15,900 
12/10/2024 0.06  0.09  0.06  0.08  6,300 
12/09/2024 0.08  0.08  0.06  0.06  7,700 
12/06/2024 0.08  0.1  0.08  0.08  22,320 
12/05/2024 0.08  0.08  0.08  0.08  5,000 
12/04/2024 0.08  0.1  0.08  0.09  21,000 
12/03/2024 0.08  0.1  0.08  0.1  13,900 
12/02/2024 0.09  0.09  0.09  0.09  1,000.00 
11/29/2024 0.09  0.09  0.09  0.09  1.00 
11/27/2024 0.09  0.1  0.09  0.09  15,000 
11/26/2024 0.09  0.09  0.09  0.09  10,000 
11/25/2024 0.1  0.1  0.09  0.09  29,798 
11/22/2024 0.1  0.1  0.1  0.1  1.00 
11/21/2024 0.1  0.1  0.09  0.1  8,300 
11/20/2024 0.1  0.1  0.09  0.09  14,200 
11/19/2024 0.12  0.12  0.12  0.12  1.00 
11/18/2024 0.1  0.12  0.1  0.12  11,200 
11/15/2024 0.12  0.12  0.12  0.12  1.00 
11/14/2024 0.12  0.12  0.12  0.12  1,100 
11/13/2024 0.12  0.12  0.12  0.12  5,300 
11/12/2024 0.09  0.11  0.09  0.11  24,700 
11/11/2024 0.07  0.12  0.07  0.1  2,900 
11/08/2024 0.11  0.11  0.09  0.09  17,100 
11/07/2024 0.11  0.12  0.11  0.12  13,000 
11/06/2024 0.12  0.12  0.12  0.12  5,100 
11/05/2024 0.12  0.12  0.11  0.11  82,400 
11/04/2024 0.11  0.12  0.10  0.12  103,700 
11/01/2024 0.12  0.12  0.11  0.11  20,400 
10/31/2024 0.12  0.12  0.10  0.11  121,800 
10/30/2024 0.1  0.12  0.08  0.12  104,000 
10/29/2024 0.09  0.09  0.09  0.09  2,500 
10/28/2024 0.10  0.10  0.07  0.07  33,362 
10/25/2024 0.07  0.10  0.06  0.10  29,100 
10/24/2024 0.06  0.07  0.06  0.07  21,400 
10/23/2024 0.06  0.06  0.06  0.06  1.00 
10/22/2024 0.07  0.07  0.06  0.06  74,930 
10/21/2024 0.07  0.07  0.07  0.07  31,600 
10/18/2024 0.06  0.07  0.06  0.07  20,000 
10/17/2024 0.06  0.06  0.06  0.06  13,000 
10/16/2024 0.06  0.06  0.06  0.06  91,500 
10/15/2024 0.06  0.07  0.06  0.06  16,400 
10/14/2024 0.06  0.06  0.04  0.06  69,200 
10/11/2024 0.04  0.06  0.04  0.06  152,637 
10/10/2024 0.03  0.04  0.03  0.04  1,000.00 
10/09/2024 0.04  0.04  0.03  0.04  10,000 
10/08/2024 0.04  0.04  0.04  0.04  5,344 
10/07/2024 0.03  0.03  0.03  0.03  4,000 
10/04/2024 0.04  0.04  0.04  0.04  4,000 
10/03/2024 0.04  0.04  0.04  0.04  1.00 
10/02/2024 0.04  0.04  0.04  0.04  1.00 
10/01/2024 0.03  0.04  0.03  0.04  3,800 
09/30/2024 0.04  0.04  0.04  0.04  1.00 
09/27/2024 0.04  0.04  0.04  0.04  1.00 
09/26/2024 0.04  0.04  0.04  0.04  1.00 
09/25/2024 0.04  0.04  0.04  0.04  1.00 
09/24/2024 0.04  0.04  0.04  0.04  1.00 
09/23/2024 0.04  0.04  0.04  0.04  4,000 
09/20/2024 0.04  0.04  0.04  0.04  4,000 

About Rafarma Pharmaceuticals Pink Sheet history

Rafarma Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Rafarma is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Rafarma Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Rafarma Pharmaceuticals stock prices may prove useful in developing a viable investing in Rafarma Pharmaceuticals
Rafarma Pharmaceuticals, Inc., a multi-product pharmaceutical company, produces and sells drugs, generic antibiotics, and specialty pharmaceuticals in Russia. As of October 19, 2020, Rafarma Pharmaceuticals, Inc. operates as a subsidiary of R. D. RAFARMA PHARMACEUTICALS operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.

Rafarma Pharmaceuticals Pink Sheet Technical Analysis

Rafarma Pharmaceuticals technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
A focus of Rafarma Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Rafarma Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Sectors Now

   

Sectors

List of equity sectors categorizing publicly traded companies based on their primary business activities
All  Next Launch Module

Rafarma Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Rafarma Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Rafarma Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Rafarma to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Rafarma Pink Sheet analysis

When running Rafarma Pharmaceuticals' price analysis, check to measure Rafarma Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rafarma Pharmaceuticals is operating at the current time. Most of Rafarma Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Rafarma Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rafarma Pharmaceuticals' price. Additionally, you may evaluate how the addition of Rafarma Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum